3.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
What analysts say about Relay Therapeutics Inc. stockExceptional growth trajectory - PrintWeekIndia
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - TradingView
Is Relay Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia
When is the best time to buy Relay Therapeutics Inc. stockMassive wealth growth - jammulinksnews.com
Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com
What drives Relay Therapeutics Inc. stock priceTremendous growth potential - PrintWeekIndia
Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com
Why Relay Therapeutics Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
what makes relay therapeutics inc. stock price move sharplyTargeted 200 Percent Gain - Newser
Is Relay Therapeutics Inc. stock overhyped or has real potentialLong Term Secure Gain Stocks - Newser
Is Relay Therapeutics Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser
RLAY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - The Globe and Mail
How Relay Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser
What makes Relay Therapeutics Inc. stock price move sharplyTrade Ready Signal - Newser
DekaBank Deutsche Girozentrale Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st
Wealth Enhancement Advisory Services LLC Makes New $41,000 Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
AI drug discovery platform Market May See a Big Move | Major Giants - openPR.com
Relay Therapeutics CEO Patel sells $219k in shares By Investing.com - Investing.com Canada
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - TradingView
BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - Yahoo Finance
13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire
Unraveling Relay Therapeutics' 9.8% Spike: A Closer Look at the Anomaly - AInvest
In the Green: Relay Therapeutics Inc (RLAY) Closes at 3.06, Up/Down -6.42 from Previous Day - DWinneX
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):